Navigation Links
New techniques improve imaging quality, not diagnosis of Barrett's esophagus
Date:3/11/2008

Bethesda, MD (March 4, 2008) Novel techniques to improve the quality of imaging are helping doctors get a better look at esophageal conditions such as Barretts esophagus (BE), but they do not necessarily improve the diagnosis or physician agreement on images, according to a study published this month in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

Researchers from the study found that the image quality of magnified images of BE that are obtained with new imaging techniques was preferred both by expert and by non-expert endoscopists. However, this higher preference did not lead to more agreement on features of interest and did not improve their ability to diagnose esophageal abnormalities.

We know that novel technologies are dramatically improving image quality, which in turn has improved the diagnostic potential of minimally invasive techniques. But we need to review these techniques to fully understand if they deliver a clinical benefit rather than just a clearer image, said Jacques Bergman, MD, PhD, from the Academic Medical Center in the Netherlands and lead author of the study. In our opinion, the subjective improvement of image quality with enhancement techniques may have limited clinical relevance in this particular setting.

In this study, the research team compared images obtained with magnifying high-resolution white light endoscopy (WLE, a standard endoscopic process), narrow band imaging (NBI), indigo carmine chromoendoscopy (ICC) and acetic acid chromoendoscopy (AAC) to determine the best techniques for detailed evaluation of BE characteristics. The team evaluated the improved quality of the images and sought to determine if the addition of these enhancement techniques would improve the agreement between observers for distinct features of disease as well as their ability to correctly identify abnormal areas. Because dysplastic and non-dysplastic BE featur
'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Biopsy techniques have made PSA test less predictive
2. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
3. Improved diagnosis of cutaneous leishmaniasis thanks to new techniques
4. MRI techniques evolving towards better assessment of liver fibrosis
5. Exploring the Use of Techniques From Neuroscience in Todays Marketing
6. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
7. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
8. NIH grant to Emory and pediatric partners aims to improve kidney transplants for children
9. Blue Cross and Blue Shields Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality
10. Outcomes Improve for Non-Hodgkin Lymphoma Patients
11. Hospital Caregivers Unveil Billboards Calling for Improved Patient Care, Quality Jobs at Community Medical Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... ... La Jolla, Calif. (Vocus) -- The physicians at Scripps ... new chief of staff of the 372-bed facility. Dr. Sedwitz will ... 1, 2010. , , , , ,During his two-year term, Dr. ... administrative staff and its board of directors. Dr. Sedwitz will play ...
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- ... -- the largest survey on teen drug abuse tracking ... that teens, intentional abuse of prescription (Rx) and over-the-counter ... with an alarming number of young people abusing medicines ... Teen Abuse of Medication Continues to Be a ...
(Date:12/14/2009)... The Hemophilia Federation of America (HFA) expresses its ... Teamsters Local 929 and the American Red Cross ... depends on skilled workers to provide clean, safe ... products such as clotting factor for use in ... The Division of Blood Services at the American ...
(Date:12/14/2009)... men whose disease had been treated, hadn,t spread, study ... appears to reduce the risk of death in male ... began in January 1986, included 668 men who,d been ... colon cancer that had not spread (nonmetastatic cancer). Every ... them about any new cancer and disease diagnoses, as ...
(Date:12/14/2009)... study finds, , , MONDAY, Dec. 14 (HealthDay News) -- ... morning without a cup or two of java: Coffee ... type 2 diabetes. , That,s the conclusion of ... you drink, the lower your risk of diabetes. Every ... reduction in the risk of diabetes, the researchers said. ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... maintain strength, not gain it, while you mend , , WEDNESDAY, ... fitness enthusiast who suffers a strained muscle, sprained ankle or ... , "Exercise can definitely be beneficial for a person dealing ... should be moved and not left in place for a ...
... April 23 Speaker Nancy Pelosi,spoke at the Congressional ... renowned heart surgeon Dr. Michael DeBakey. Below are the,Speaker,s ... indeed to join President Bush,leaders of the House and ... commend Senator Hutchison and my colleague Representative Al,Green, and ...
... 23 Global leaders are,rediscovering the importance of ... for competing in today,s economic,environment, according to a ... study further reveals -- Competitive Intelligence adds value ... raw competitive data,into actionable insights that have a ...
... (EGPAF), a world leader in the fight against pediatric ... $1 million to researchers to support the development of ... PhD, professor of medicine at the University of Massachusetts ... MD, professor of pediatrics and director of the division ...
... and Industry Directions Launch New Study, FALLS ... and Industry Directions Inc., in close,association with research ... to respond to a new survey on current ... objectives,business processes and practices, information systems and applications, ...
... Blocking IL-11 protein prevents inflammation, hints of new treatments ... Scientists say they may have discovered how tumors develop ... new treatments for gastric cancer. , In a study ... the International Ludwig Institute for Cancer Research (LICR) found ...
Other Medicine News:Health News:Exercise Plays Role in Recovery From Sports Injuries 2Health News:Pelosi: 'By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions' 2Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 3Health News:Risk Management: Best Practices for Medical Device Profitability 2Health News:Scientists Discover How Stomach Tumors Form 2
(Date:12/14/2009)... Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: ... program encouraging health professionals to help maintain the ... on long-term androgen deprivation therapy (ADT). Nearly ... treatment for prostate cancer that, while highly effective ... loss and increase a man,s risk for osteoporosis. ...
(Date:12/14/2009)... Ohr Pharmaceutical Inc. (OTC Bulletin Board: OHRP) ... Inc, headquartered in Irvine, CA, with offices also ... for investor relations and corporate communications. Ohr ... on developing advanced drugs for underserved therapeutic needs. ... large, global markets: OHR/AVR118 for the treatment of ...
(Date:12/14/2009)... Calif. and REHOVOT, Israel, Dec. 14 ... technology and services resource for pathologists, oncologists and ... today jointly announced that they will collaborate on ... non-invasive test for the early detection of non-small ... patient,s sputum and was originally developed at the ...
Breaking Medicine Technology:Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 2Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 4New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 1New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 2New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 1AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 2AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 4AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 5AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 6AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 7US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7
... Mass., April 3, 2008 Thermo Fisher,Scientific Inc. ... serving science, announced,that it has received U.S. Food ... test designed to screen for methicillin-resistant,Staphylococcus aureus (MRSA), ... Positive Predictive Value commercially available for MRSA,screening, Spectra ...
... N.J., April 3, 2008 Medarex, Inc.,(Nasdaq: ... statement in response to the,announcement by Pfizer ... 3 clinical,trial of front-line treatment with Pfizer,s ... patients with advanced,melanoma. Dr. Geoffrey M. Nichol, ...
Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4Medarex Announces Ipilimumab Program Continues to Move Forward 2Medarex Announces Ipilimumab Program Continues to Move Forward 3Medarex Announces Ipilimumab Program Continues to Move Forward 4Medarex Announces Ipilimumab Program Continues to Move Forward 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: